Clinical Trial Update: A Bioequivalence Study of Tobradex AF [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 bioequivalence trial of Tobradex AF for cataract patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Tobradex AF (tobramycin/dexamethasone)

Snippet

Sponsor: Alcon Research | Conditions: Cataract | Phase 3 | Status: COMPLETED